GuruFocus.com19d agoneutral
Novo Nordisk Launches Ozempic Pill in U.S.Oral version targets broader access as GLP-1 demand grows
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
高シグナルの見出しのみ — マクロイベント、決算、M&A、規制。リスト記事とアナリストのクリックベイトはデフォルトでフィルタ。1時間ごとに更新。
Oral version targets broader access as GLP-1 demand grows
Novo will sell 1.5 mg, 4 mg and 9 mg Ozempic pills as it rebrands Rybelsus in the US.